Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00333151

Public ClinicalTrials.gov record NCT00333151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 4:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect on Glycemic Control of Liraglutide in Combination With Rosiglitazone Plus Metformin Versus Rosiglitazone Plus Metformin in Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT00333151
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
576 participants

Conditions and interventions

Interventions

  • liraglutide Drug
  • metformin Drug
  • rosiglitazone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Jul 31, 2007
Completion
Jul 31, 2007
Last update posted
Jan 24, 2017

2006 – 2007

United States locations

U.S. sites
71
U.S. states
28
U.S. cities
62
Facility City State ZIP Site status
Novo Nordisk Investigational Site Goodyear Arizona 85395
Novo Nordisk Investigational Site Colton California 92324
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Long Beach California 90822
Novo Nordisk Investigational Site Los Angeles California 90024
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Mission Viejo California 92691
Novo Nordisk Investigational Site Orange California 92869
Novo Nordisk Investigational Site Santa Ana California 92705
Novo Nordisk Investigational Site Santa Barbara California 93105
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site New Britain Connecticut 06050
Novo Nordisk Investigational Site Washington D.C. District of Columbia 20010
Novo Nordisk Investigational Site Fort Myers Florida 33907
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Lake Mary Florida 32746
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Athens Georgia 30606
Novo Nordisk Investigational Site Atlanta Georgia 30032
Novo Nordisk Investigational Site Atlanta Georgia 30034
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Powder Springs Georgia 30127
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Peoria Illinois 61615
Novo Nordisk Investigational Site New Albany Indiana 47150
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808
Novo Nordisk Investigational Site New Orleans Louisiana 70121
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Tupelo Mississippi 38801
Novo Nordisk Investigational Site St Louis Missouri 63110
Novo Nordisk Investigational Site Reno Nevada 89502
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Plainsboro New Jersey 08536
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site Brooklyn New York 11203
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Rochester New York 14621
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599-7172
Novo Nordisk Investigational Site Durham North Carolina 27710
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Cleveland Ohio 44195
Novo Nordisk Investigational Site Columbus Ohio 43203
Novo Nordisk Investigational Site Columbus Ohio 43212
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Duncan South Carolina 29334
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site Houston Texas 77025
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site Lubbock Texas 79430-8183
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site San Antonio Texas 78209
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Salt Lake City Utah 84102
Novo Nordisk Investigational Site Newport News Virginia 23606
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Spokane Washington 99218
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00333151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2017 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00333151 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →